160 related articles for article (PubMed ID: 11961040)
1. Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel.
Ekins S; Crumb WJ; Sarazan RD; Wikel JH; Wrighton SA
J Pharmacol Exp Ther; 2002 May; 301(2):427-34. PubMed ID: 11961040
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore modeling for hERG channel facilitation.
Yamakawa Y; Furutani K; Inanobe A; Ohno Y; Kurachi Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):161-6. PubMed ID: 22244872
[TBL] [Abstract][Full Text] [Related]
3. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
Durdagi S; Duff HJ; Noskov SY
J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
[TBL] [Abstract][Full Text] [Related]
4. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Cavalli A; Poluzzi E; De Ponti F; Recanatini M
J Med Chem; 2002 Aug; 45(18):3844-53. PubMed ID: 12190308
[TBL] [Abstract][Full Text] [Related]
5. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
Rampe D; Murawsky MK; Grau J; Lewis EW
J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
Vigneault P; Kaddar N; Bourgault S; Caillier B; Pilote S; Patoine D; Simard C; Drolet B
J Cardiovasc Pharmacol; 2011 Jun; 57(6):690-5. PubMed ID: 21394035
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches.
Pearlstein RA; Vaz RJ; Kang J; Chen XL; Preobrazhenskaya M; Shchekotikhin AE; Korolev AM; Lysenkova LN; Miroshnikova OV; Hendrix J; Rampe D
Bioorg Med Chem Lett; 2003 May; 13(10):1829-35. PubMed ID: 12729675
[TBL] [Abstract][Full Text] [Related]
8. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
Aronov AM
J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
[TBL] [Abstract][Full Text] [Related]
10. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
Ekins S; Balakin KV; Savchuk N; Ivanenkov Y
J Med Chem; 2006 Aug; 49(17):5059-71. PubMed ID: 16913696
[TBL] [Abstract][Full Text] [Related]
11. Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.
Crumb WJ; Ekins S; Sarazan RD; Wikel JH; Wrighton SA; Carlson C; Beasley CM
Pharm Res; 2006 Jun; 23(6):1133-43. PubMed ID: 16715368
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
13. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of hERG potassium channel blockade by antipsychotics.
Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):457-65. PubMed ID: 17982510
[TBL] [Abstract][Full Text] [Related]
15. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.
Volberg WA; Koci BJ; Su W; Lin J; Zhou J
J Pharmacol Exp Ther; 2002 Jul; 302(1):320-7. PubMed ID: 12065733
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
17. BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.
Zhang M; Korolkova YV; Liu J; Jiang M; Grishin EV; Tseng GN
Biophys J; 2003 May; 84(5):3022-36. PubMed ID: 12719233
[TBL] [Abstract][Full Text] [Related]
18. APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go-related gene potassium channels.
Diochot S; Loret E; Bruhn T; Béress L; Lazdunski M
Mol Pharmacol; 2003 Jul; 64(1):59-69. PubMed ID: 12815161
[TBL] [Abstract][Full Text] [Related]
19. Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Keserü GM
Bioorg Med Chem Lett; 2003 Aug; 13(16):2773-5. PubMed ID: 12873512
[TBL] [Abstract][Full Text] [Related]
20. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
